
Sign up to save your podcasts
Or


Today we’re talking to Peter Rahfeld, CSO of ABOzymes; and we discuss how Peter’s company hopes to make blood types obsolete by being able to change any blood to Type O. Learn about the science and the business behind this breakthrough right here, right now, on the Modern CTO Podcast!
Learn more at https://www.abozymes.com
By ProSeries Media4.9
8686 ratings
Today we’re talking to Peter Rahfeld, CSO of ABOzymes; and we discuss how Peter’s company hopes to make blood types obsolete by being able to change any blood to Type O. Learn about the science and the business behind this breakthrough right here, right now, on the Modern CTO Podcast!
Learn more at https://www.abozymes.com

532 Listeners

290 Listeners

699 Listeners

1,087 Listeners

625 Listeners

153 Listeners

42 Listeners

303 Listeners

144 Listeners

235 Listeners

210 Listeners

212 Listeners

130 Listeners

94 Listeners

209 Listeners